Cargando…
The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
Psychiatric side effects are well known from treatment with systemic corticosteroids. It is, however, unclear whether inhaled corticosteroids (ICS) have psychiatric side effects in patients with COPD. We conducted a nationwide cohort study in all Danish COPD outpatients who had respiratory medicine...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533368/ https://www.ncbi.nlm.nih.gov/pubmed/34680609 http://dx.doi.org/10.3390/biomedicines9101492 |
_version_ | 1784587296062832640 |
---|---|
author | Jordan, Alexander Sivapalan, Pradeesh Eklöf, Josefin Vestergaard, Jakob B. Meteran, Howraman Saeed, Mohamad Isam Biering-Sørensen, Tor Løkke, Anders Seersholm, Niels Jensen, Jens Ulrik Stæhr |
author_facet | Jordan, Alexander Sivapalan, Pradeesh Eklöf, Josefin Vestergaard, Jakob B. Meteran, Howraman Saeed, Mohamad Isam Biering-Sørensen, Tor Løkke, Anders Seersholm, Niels Jensen, Jens Ulrik Stæhr |
author_sort | Jordan, Alexander |
collection | PubMed |
description | Psychiatric side effects are well known from treatment with systemic corticosteroids. It is, however, unclear whether inhaled corticosteroids (ICS) have psychiatric side effects in patients with COPD. We conducted a nationwide cohort study in all Danish COPD outpatients who had respiratory medicine specialist-verified COPD, age ≥40 years, and no previous cancer. Prescription fillings of antidepressants and risk of admissions to psychiatric hospitals with either depression, anxiety or bipolar disorder were assessed by Cox proportional hazards models. We observed a dose-dependent increase in the risk of antidepressant-use with ICS cumulated dose (HR 1.05, 95% CI 1.03–1.07, p = 0.0472 with low ICS exposure, HR 1.10, 95% CI 1.08–1.12, p < 0.0001 with medium exposure, HR 1.15, 95% CI 1.11–1.15, p < 0.0001 with high exposure) as compared to no ICS exposure. We found a discrete increased risk of admission to psychiatric hospitals in the medium and high dose group (HR 1.00, 95% CI 0.98–1.03, p = 0.77 with low ICS exposure, HR 1.07, 95% CI 1.05–1.10, p < 0.0001 with medium exposure, HR 1.13, 95% CI 1.10–1.15, p < 0.0001 with high exposure). The association persisted when stratifying for prior antidepressant use. Thus, exposure to ICS was associated with a small to moderate increase in antidepressant-use and psychiatric admissions. |
format | Online Article Text |
id | pubmed-8533368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85333682021-10-23 The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients Jordan, Alexander Sivapalan, Pradeesh Eklöf, Josefin Vestergaard, Jakob B. Meteran, Howraman Saeed, Mohamad Isam Biering-Sørensen, Tor Løkke, Anders Seersholm, Niels Jensen, Jens Ulrik Stæhr Biomedicines Article Psychiatric side effects are well known from treatment with systemic corticosteroids. It is, however, unclear whether inhaled corticosteroids (ICS) have psychiatric side effects in patients with COPD. We conducted a nationwide cohort study in all Danish COPD outpatients who had respiratory medicine specialist-verified COPD, age ≥40 years, and no previous cancer. Prescription fillings of antidepressants and risk of admissions to psychiatric hospitals with either depression, anxiety or bipolar disorder were assessed by Cox proportional hazards models. We observed a dose-dependent increase in the risk of antidepressant-use with ICS cumulated dose (HR 1.05, 95% CI 1.03–1.07, p = 0.0472 with low ICS exposure, HR 1.10, 95% CI 1.08–1.12, p < 0.0001 with medium exposure, HR 1.15, 95% CI 1.11–1.15, p < 0.0001 with high exposure) as compared to no ICS exposure. We found a discrete increased risk of admission to psychiatric hospitals in the medium and high dose group (HR 1.00, 95% CI 0.98–1.03, p = 0.77 with low ICS exposure, HR 1.07, 95% CI 1.05–1.10, p < 0.0001 with medium exposure, HR 1.13, 95% CI 1.10–1.15, p < 0.0001 with high exposure). The association persisted when stratifying for prior antidepressant use. Thus, exposure to ICS was associated with a small to moderate increase in antidepressant-use and psychiatric admissions. MDPI 2021-10-18 /pmc/articles/PMC8533368/ /pubmed/34680609 http://dx.doi.org/10.3390/biomedicines9101492 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jordan, Alexander Sivapalan, Pradeesh Eklöf, Josefin Vestergaard, Jakob B. Meteran, Howraman Saeed, Mohamad Isam Biering-Sørensen, Tor Løkke, Anders Seersholm, Niels Jensen, Jens Ulrik Stæhr The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title | The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title_full | The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title_fullStr | The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title_full_unstemmed | The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title_short | The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients |
title_sort | association between use of ics and psychiatric symptoms in patients with copd—a nationwide cohort study of 49,500 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533368/ https://www.ncbi.nlm.nih.gov/pubmed/34680609 http://dx.doi.org/10.3390/biomedicines9101492 |
work_keys_str_mv | AT jordanalexander theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT sivapalanpradeesh theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT eklofjosefin theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT vestergaardjakobb theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT meteranhowraman theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT saeedmohamadisam theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT bieringsørensentor theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT løkkeanders theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT seersholmniels theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT jensenjensulrikstæhr theassociationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT jordanalexander associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT sivapalanpradeesh associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT eklofjosefin associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT vestergaardjakobb associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT meteranhowraman associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT saeedmohamadisam associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT bieringsørensentor associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT løkkeanders associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT seersholmniels associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients AT jensenjensulrikstæhr associationbetweenuseoficsandpsychiatricsymptomsinpatientswithcopdanationwidecohortstudyof49500patients |